Immunomatrix

Lentigen Admin & Technical Inc, located in Gaithersburg, MD, specializes in cell and gene therapy services, providing expertise in CGT manufacturing and strategic process consultation. Their offerings include analytical assay development, cell therapy manufacturing for clinical use, and quality and regulatory support across various lentiviral vector platforms. With a commitment to speed in achieving commercial readiness, the company is well-equipped for both clinical applications and moving towards commercial scale production. Lentigen also features advanced technologies such as the CliniMACS Prodigy Platform and the MACSQuant Analyzer to support their comprehensive service range. Generated from the website

BiomX Inc., based in Gaithersburg, MD, specializes in developing customized phage therapies aimed at eradicating harmful bacteria associated with chronic diseases such as cystic fibrosis and diabetic foot osteomyelitis. The company leverages its proprietary XMarker platform for microbiome-based biomarker discovery to enhance the efficacy of these therapies and tailor treatments to individual patient needs. With its foundation rooted in research from the Weizmann Institute of Science and MIT, BiomX is at the forefront of phage therapy innovation, collaborating with major pharmaceutical partners like Janssen Pharmaceuticals and Boehringer Ingelheim to advance its clinical pipeline. The company's commitment to harnessing cutting-edge science positions it as a leader in the development of advanced therapeutics for combating bacterial infections. Generated from the website

The Osteogenesis Imperfecta Foundation (OIF) is a national health organization dedicated to enhancing the lives of individuals impacted by osteogenesis imperfecta (OI) through research, education, awareness, and mutual support. With a commitment to improving understanding and treatment options for OI, the foundation offers a variety of resources, programs, and events aimed at connecting the OI community and fostering collaboration among medical professionals. The OIF plays a crucial role in supporting research initiatives and providing educational opportunities, such as conferences and webinars, to empower families and individuals affected by OI. Through its information center and support networks, the organization ensures accessible, medically-verified knowledge and a platform for sharing experiences and challenges related to living with this rare bone disease. Generated from the website